Lipocine Inc.

NASDAQ: LPCN · Real-Time Price · USD
3.03
-0.01 (-0.33%)
At close: Aug 15, 2025, 3:59 PM
3.04
0.33%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lipocine Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.21M 4.77M 3.15M 2.95M
Short-Term Investments
15.43M 17.26M 29.38M 41.67M
Long-Term Investments
n/a n/a 3.25M 2.02M
Other Long-Term Assets
23.75K 23.75K -42.59M 4.07M
Receivables
120.45K 52.25K 659.86K 247.25K
Inventory
n/a n/a n/a n/a
Other Current Assets
567.91K 773.42K 945.32K n/a
Total Current Assets
22.32M 22.86M 34.14M 46.38M
Property-Plant & Equipment
165.07K 116.09K 131.59K 7.21K
Goodwill & Intangibles
n/a n/a -3.25M n/a
Total Long-Term Assets
188.83K 139.85K 3.41M 6.1M
Total Assets
22.51M 23M 37.54M 52.48M
Account Payables
271.7K 1.4M 600.39K 1.29M
Deferred Revenue
320K n/a n/a 1.02M
Short-Term Debt
n/a n/a n/a 2.31M
Other Current Liabilities
-438.63K 17.17K n/a 1M
Total Current Liabilities
1.51M 2.63M 1.68M 5.62M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 229.86K 1.3M
Total Long-Term Liabilities
n/a n/a 229.86K 1.3M
Total Liabilities
1.51M 2.63M 1.91M 6.91M
Total Debt
438.63K 17.17K n/a 2.31M
Common Stock
8.86K 8.86K 8.85K 8.83K
Retained Earnings
-199.77M -199.78M -183.43M -172.67M
Comprehensive Income
9.14K 7.26K -20.32K -18.02K
Shareholders Equity
21M 20.37M 35.63M 45.57M
Total Investments
15.43M 17.26M 29.38M 43.69M